Over the decades, many strains of disease-causing bacteria have evolved defenses to even the most potent antibiotics, setting ...

Researchers report how Paenibacillus avoids harm by its own antibiotic — information that is crucial for developing new drug ...

The funding will support final development, clinical validation, regulatory approval, and commercial launch of an ultra-rapid AST platform.